EMA has recommended granting a marketing authorisation in the European Union (EU) for mCombriax, a messenger RNA vaccine for protecting people …
Read more: First combined COVID-19 and influenza vaccine for people 50 years and older – EMA
Read more: First combined COVID-19 and influenza vaccine for people 50 years and older – EMA